Abstract: A rolled-up transformer structure comprises a multilayer sheet having a rolled configuration comprising multiple turns about a longitudinal axis. The multilayer sheet comprises more than one conductive pattern layer on a strain-relieved layer, including a first conductive film and a second conductive film separated from the first conductive film in a thickness direction. The first conductive film comprises an even number of primary conductive strips, where each primary conductive strip has a length extending in the rolling direction, and the second conductive film comprises an even number of secondary conductive strips, where each secondary conductive strip has a length extending in the rolling direction. In the rolled configuration, turns of the primary conductive strips and turns of the secondary conductive strips wrap around the longitudinal axis. The primary conductive strips serve as a primary winding and the secondary conductive strips serve as a secondary winding of the rolled-up transformer structure.

Abstract: Many areas of biomedical research depend on the analysis of uncommon variations in individual genes or transcripts. Here we describe a method that can quantify such variation at a scale and ease heretofore unattainable. Each DNA molecule in a collection of such molecules is converted into a single particle to which thousands of copies of DNA identical in sequence to the original are bound. This population of beads then corresponds to a one-to-one representation of the starting DNA molecules. Variation within the original population of DNA molecules can then be simply assessed by counting fluorescently-labeled particles via flow cytometry. Millions of individual DNA molecules can be assessed in this fashion with standard laboratory equipment. Moreover, specific variants can be isolated by flow sorting and employed for further experimentation.

Abstract: An ultraviolet light emitting semiconductor chip, its use in a LED, and methods of its fabrication are disclosed. The semiconductor chip can include a buffer layer of AlxGa1-xN, where 0<x?1 having a thickness from about 10 ?m to about 3 mm and defining apertures in the thickness of the buffer layer formed due to lateral overgrowth of the buffer layer over a grooved basal substrate. A n-junction LED layer overlying the buffer layer, a multiple quantum well LED layer overlying the n-junction LED layer, and a p-junction LED layer overlying the multiple quantum well LED layer are also included in the chip, where all of the LED layers comprise AlxGa1-xN, where 0<x?1.

Abstract: A wireless communication device includes, in part, at least one antenna for receiving or transmitting a signal, and a cancelation circuit adapted to cancel or reduce the self-interference signal. The cancelation circuit includes, in part, a control block, N delay and attenuation paths, a combiner, and a subtractor. Each path includes a delay element and a variable attenuator whose attenuation level varies in response to a control signal generated by the control block. Each path receives a sample of the transmit signal and generates a delayed and attenuated (weighted) version of the sample signal. The combiner combines the N delayed and weighted versions of the sample signal to construct a signal representative of the self-interference signal. The subtractor subtracts the constructed signal from the received signal thereby the cancel or reduce the self-interference signal therefrom.

Abstract: Nitrogen-containing biphenyl compounds as represented by formula (I), pharmaceutically acceptable salts or derivatives thereof, pharmaceutical compositions, and preparation methods therefore, and anti-HIV-1 use of the compound. Each substituent group in formula (I) is as defined in the description.

Abstract: The present invention provides immunogenic compositions against Campylobacter and methods for using the immunogenic composition to generate an immune response against Campylobacter and/or reduce intestinal colonization by Campylobacter.

Abstract: The present invention provides compositions for inhibiting the activity of an insect pest against a subject (or repelling an insect pest from an environment or preventing attraction to an environment) which compositions comprise geranylacetone as an active ingredient plus a carrier plus a further active ingredient selected from the list consisting of: 6-Methyl-hepten-2-one, octanal, plus optional other chemicals. Also provided are related materials and methods of use.

Abstract: In certain embodiments, an optical device and a method of use is provided. The optical device includes a fiber Bragg grating having a substantially periodic refractive index modulation along a length of the fiber Bragg grating. The fiber Bragg grating has a power transmission spectrum with a plurality of local transmission minima, wherein each pair of neighboring local transmission minima has a local transmission maximum therebetween. The local transmission maximum has a maximum power at a transmission peak wavelength. The optical device further includes a narrowband optical source in optical communication with a first optical path and a second optical path.

Abstract: A luminescent device including an emission layer having luminescent nanoclusters is provided. The luminescent nanoclusters can be phosphorescent metal halides. The luminescent device can emit IR, NIR, colored, or white light and be pumped electrically or optically. A method for manufacturing a luminescent device including an emission layer having luminescent nanoclusters is also provided.

Abstract: A power converter having components enclosed by legs of a first inductor is described. The first inductor is fabricated on the top surface of a substrate along the perimeter of the substrate. A second inductor is fabricated on the bottom surface of the substrate and mirrors the first inductor. Electromagnetic cancellation is provided when the current flow in the second inductor is opposite of the current flow in the first inductor.

Abstract: The disclosure provides lantibiotics geobacillin I and geobacillin II from Geobacillus thermodenitrificans, compositions comprising the lantibiotics, and methods of use of the lantibiotics. Further disclosed are the sequences of lantibiotics geobacillin I and geobacillin I, and alternative structures of geobacillin I and geobacillin II comprising amino acid substitutions. Antimicrobial compositions comprising one or more isolated geobacillins and a pharmaceutically acceptable carrier, and methods of reducing reproduction of bacteria comprising administering to a subject a therapeutically effective amount of the antimicrobial composition are also provided.

Abstract: The present invention provides a sand art simulation system and method, which transfers an image into sand art. Analyze contour lines and feature points of objects in the image to find out which contour line can be drawn at the same time. Divide the image into a plurality of blocks, and analyze sand spilling ways at each block. Simulate sand floating in the air, moving and heaping to make a sand-spread plane. Then draw the contour lines on the sand-spread plane to show the sand art of the image.

Abstract: An Axially Graded Index LEns (AGILE) is provided. Such optical elements can provide optical concentration in excess of the free-space brightness theorem limit, because of the increased refractive index at the output of the concentrator compared to the input. Optical contact (i.e., no intervening low index material) between the AGILE and the absorbing element (or an optical source) can be employed to ensure no loss of brightness at the interface between the AGILE and the absorbing element (or source). Although solar cell concentration is a significant application of this technology, there are various other applications, such as increasing the efficiency of optical emission, and providing transmissive optical windows that include optically cloaked regions.

Abstract: The invention provides a peptide or peptidomimetic that is derived from or based upon the amino acid sequence of the C-terminal ?-helix or hypervariable region (HVR) or a Ras protein, a nucleic acid encoding the peptide or peptidomimetic, and methods employing the same.

Abstract: An electronic package module includes a circuit board having a supporting surface, at least one first electronic component, at least one second electronic component, and at least one molding compound. The first and second electronic components are mounted on the supporting surface. The molding compound is disposed on the supporting surface and covers the supporting surface partially. The molding compound encapsulates the first electronic component yet not the second electronic component.

Abstract: Phase error in MR imaging is corrected in real time by providing adaptive RF pulses and corresponding adaptive magnetic field gradients to mitigate the effect of phase error in the imaging subject. A real time phase error map is obtained, and then adaptive RF pulses and corresponding field gradients are applied that remove the problematic effects of the phase error. Depending on details of the MR imaging mode being employed, there are several ways this removal can be done. Phase error can be cancelled by providing RF pulses that make the phase in the imaging subject uniform. Another approach is to make the adaptive RF pulses insensitive to the phase errors that are present.

Abstract: An integrated circuit for a radio frequency (RF) circuit such as a voltage controlled oscillator or an injection locked frequency divider is provided. The integrated circuit architecture includes a primary LC tank circuit comprising a first inductor and a first capacitive device connected in parallel and one or more secondary LC tank circuits, each comprising an inductor and a capacitive device connected in parallel. Each of the one or more secondary LC tank circuits is strongly coupled to the primary LC tank circuit and to each other either electrically, magnetically or a combination of electrically and magnetically.

Abstract: There is provided a 3-dimensional coordinate specifying device which can accurately specify a set or sets of optional coordinates in a 3-dimensional space by a simple manipulation. The 3-dimensional coordinate specifying device includes a standard plane setting section 22 for setting an optional standard flat plane 31 in a 3-dimensional space, a standard point determining section 23 for determining values of coordinates of an optional point on the set standard flat plane 31, a light beam emitting section 25 for emitting an imaginary light beam 33 at an optional angle from the determined standard point 32, a point specifying section 26 for specifying an optional point on the emitted imaginary light beam, and a coordinate calculating section 27 for calculating 3-dimensional coordinates of the specified point.

Abstract: A pixel having a simplified structure can compensate for the threshold voltage of a driving transistor thereof. The pixel includes an organic light emitting diode (OLED) having a cathode electrode coupled to a second power source, a storage capacitor coupled between a data line and a first node, a second transistor having a first electrode coupled to a first power source, a second electrode coupled to an anode electrode of the OLED, and a gate electrode coupled to the first node, a first transistor coupled between the first node and the second electrode of the second transistor, a gate electrode of the first transistor being coupled to a current scan line, and a third transistor coupled between the second electrode of the second transistor and the anode electrode of the OLED, a gate electrode of the third transistor being coupled to a control line.

Abstract: The present invention relates to compositions, methods, and kits for treating cancers with HER2 targeting agents and preventing resistance thereto. In particular embodiments, non-HER2-amplified cancers are treated with HER2 targeting agents, wherein the cancer stem cells in the cancer express HER2 and/or HER2 indicator marker. The present invention also relates to compositions, methods, and kits for detecting expression of HER2 and/or a HER2 indicator marker in non-HER2-amplified cancer samples from a subject, and identifying the subject as responsive to treatment with a HER2 targeting agent and/or treating the subject with a HER2 targeting agent.